Donate Help Contact The AHA Sign In Home
American Heart Association
Hypertension
Search: search_blue_button Advanced Search
Hypertension. 1998;31:459-462

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Brem, A. S.
Right arrow Articles by Morris, D. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Brem, A. S.
Right arrow Articles by Morris, D. J.

(Hypertension. 1998;31:459.)
© 1998 American Heart Association, Inc.


Scientific Contributions

Localization of 2 11ß-OH Steroid Dehydrogenase Isoforms in Aortic Endothelial Cells

Andrew S. Brem; Robert B. Bina; Thomas C. King; David J. Morris

From the Brown University School of Medicine; Rhode Island and Miriam Hospitals; Departments of Pediatrics (Nephrology) and Laboratory Medicine, Providence RI.

Correspondence to Andrew S. Brem, MD, Division of Pediatric Nephrology, Rhode Island Hospital, 593 Eddy Street, Providence RI 02903. E-mail: Andrew_Brem{at}Brown.edu

11ß-hydroxysteroid dehydrogenase (11ß-HSD) is expressed in vascular smooth muscle cells (VSMC) but has not been reported to be present in vascular endothelial cells. This enzyme assists in regulating the cellular concentration of active endogenous glucocorticoids (GCs). We have observed that endothelium intact rat aortic rings express message for both Type 1 and Type 2 11ß-HSD whereas primary cultures of VSMC express only mRNA for the Type I isoform. Since GCs diminish prostacyclin synthesis in endothelial cells, we hypothesized that 11ß-HSD is present in vascular endothelial cells. In primary cultures of rat aortic endothelial (RAE) cells, mRNA from both isoforms of 11ß-HSD could be detected by RT-PCR with higher levels of the Type 1 isoform. The oxo-reductase reaction "activating" 11-dehydro metabolites back to the parent steroid is the preferred enzyme direction (12:1 after a 120 minutes steroid incubation) in intact RAE cells. When RAE cells are grown in the presence of antisense oligonucleotides specific for Type 1 11ß-HSD, oxo-reductase activity is decreased by approximately 50% but the dehydrogenase reaction, which inactivates endogenous GCs and is characteristic of the Type 2 isoform, is unaffected. Thus endothelial cells appear to express both isoforms of 11ß-HSD; the Type 1 isoform dominates functioning in the oxo-reductase mode. Inhibition of the oxo-reductase reaction may lower the local concentrations of GC and indirectly allow for increased production of prostacyclin in endothelial cells.


Key Words: endothelial cells • glucocorticoids • 11ß-hydroxysteroid dehydrogenase • hypertension • corticosterone

Abbreviations: 11ß-HSD = 11ß-hydroxysteroid dehydrogenase • GC = glucocorticoid • VSMC = vascular smooth muscle cells • RAE = rat aortic endothelial • LDL = low density lipoprotein • VSM = vascular smooth muscle




This article has been cited by other articles:


Home page
Cardiovasc ResHome page
Y. Liu, D. Mladinov, J. L. Pietrusz, K. Usa, and M. Liang
Glucocorticoid response elements and 11{beta}-hydroxysteroid dehydrogenases in the regulation of endothelial nitric oxide synthase expression
Cardiovasc Res, January 1, 2009; 81(1): 140 - 147.
[Abstract] [Full Text] [PDF]


Home page
J Mol EndocrinolHome page
S. Senesi, P. Marcolongo, I. Manini, R. Fulceri, V. Sorrentino, M. Csala, G. Banhegyi, and A. Benedetti
Constant expression of hexose-6-phosphate dehydrogenase during differentiation of human adipose-derived mesenchymal stem cells
J. Mol. Endocrinol., September 1, 2008; 41(3): 125 - 133.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
M. Caprio, B. G. Newfell, A. la Sala, W. Baur, A. Fabbri, G. Rosano, M. E. Mendelsohn, and I. Z. Jaffe
Functional Mineralocorticoid Receptors in Human Vascular Endothelial Cells Regulate Intercellular Adhesion Molecule-1 Expression and Promote Leukocyte Adhesion
Circ. Res., June 6, 2008; 102(11): 1359 - 1367.
[Abstract] [Full Text] [PDF]


Home page
Eur J EndocrinolHome page
B. R Walker
Glucocorticoids and Cardiovascular Disease
Eur. J. Endocrinol., November 1, 2007; 157(5): 545 - 559.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
K. Usa, R. J. Singh, B. C. Netzel, Y. Liu, H. Raff, and M. Liang
Renal interstitial corticosterone and 11-dehydrocorticosterone in conscious rats
Am J Physiol Renal Physiol, July 1, 2007; 293(1): F186 - F192.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
A. R. Dover, P. W. F. Hadoke, L. J. Macdonald, E. Miller, D. E. Newby, and B. R. Walker
Intravascular Glucocorticoid Metabolism during Inflammation and Injury in Mice
Endocrinology, January 1, 2007; 148(1): 166 - 172.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
T. Sugiyama, T. Yoshimoto, K. Tsuchiya, N. Gochou, Y. Hirono, T. Tateno, N. Fukai, M. Shichiri, and Y. Hirata
Aldosterone Induces Angiotensin Converting Enzyme Gene Expression via a JAK2-Dependent Pathway in Rat Endothelial Cells
Endocrinology, September 1, 2005; 146(9): 3900 - 3906.
[Abstract] [Full Text] [PDF]


Home page
JEMHome page
A. Hermanowski-Vosatka, J. M. Balkovec, K. Cheng, H. Y. Chen, M. Hernandez, G. C. Koo, C. B. Le Grand, Z. Li, J. M. Metzger, S. S. Mundt, et al.
11{beta}-HSD1 inhibition ameliorates metabolic syndrome and prevents progression of atherosclerosis in mice
J. Exp. Med., August 15, 2005; 202(4): 517 - 527.
[Abstract] [Full Text] [PDF]


Home page
Endocr. Rev.Home page
J. W. Tomlinson, E. A. Walker, I. J. Bujalska, N. Draper, G. G. Lavery, M. S. Cooper, M. Hewison, and P. M. Stewart
11{beta}-Hydroxysteroid Dehydrogenase Type 1: A Tissue-Specific Regulator of Glucocorticoid Response
Endocr. Rev., October 1, 2004; 25(5): 831 - 866.
[Abstract] [Full Text] [PDF]


Home page
Recent Prog Horm ResHome page
J. R. Seckl, N. M. Morton, K. E. Chapman, and B. R. Walker
Glucocorticoids and 11beta-Hydroxysteroid Dehydrogenase in Adipose Tissue
Recent Prog. Horm. Res., January 1, 2004; 59(1): 359 - 393.
[Abstract] [Full Text]


Home page
HypertensionHome page
C. Christy, P. W.F. Hadoke, J. M. Paterson, J. J. Mullins, J. R. Seckl, and B. R. Walker
11{beta}-Hydroxysteroid Dehydrogenase Type 2 in Mouse Aorta: Localization and Influence on Response to Glucocorticoids
Hypertension, October 1, 2003; 42(4): 580 - 587.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
K. M. Rogers, C. A. Bonar, J. L. Estrella, and S. Yang
Inhibitory effect of glucocorticoid on coronary artery endothelial function
Am J Physiol Heart Circ Physiol, November 1, 2002; 283(5): H1922 - H1928.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
D. Xiao, X. Huang, S. Bae, C. A. Ducsay, and L. Zhang
Cortisol-mediated potentiation of uterine artery contractility: effect of pregnancy
Am J Physiol Heart Circ Physiol, July 1, 2002; 283(1): H238 - H246.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
B. E. ORSIDA, Z. S. KROZOWSKI, and E. H. WALTERS
Clinical Relevance of Airway 11beta -Hydroxysteroid Dehydrogenase Type II Enzyme in Asthma
Am. J. Respir. Crit. Care Med., April 1, 2002; 165(7): 1010 - 1014.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
P. W.F. Hadoke, C. Christy, Y. V. Kotelevtsev, B. C. Williams, C. J. Kenyon, J. R. Seckl, J. J. Mullins, and B. R. Walker
Endothelial Cell Dysfunction in Mice After Transgenic Knockout of Type 2, but Not Type 1, 11{beta}-Hydroxysteroid Dehydrogenase
Circulation, December 4, 2001; 104(23): 2832 - 2837.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
F. Ruschitzka, T. Quaschning, G. Noll, A. deGottardi, M. F. Rossier, F. Enseleit, D. Hurlimann, T. F. Luscher, and S. G. Shaw
Endothelin 1 Type A Receptor Antagonism Prevents Vascular Dysfunction and Hypertension Induced by 11{beta}-Hydroxysteroid Dehydrogenase Inhibition : Role of Nitric Oxide
Circulation, June 26, 2001; 103(25): 3129 - 3135.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
J. R. Seckl and B. R. Walker
Minireview: 11{beta}-Hydroxysteroid Dehydrogenase Type 1-- A Tissue-Specific Amplifier of Glucocorticoid Action
Endocrinology, April 1, 2001; 142(4): 1371 - 1376.
[Abstract] [Full Text]


Home page
HypertensionHome page
H. Hatakeyama, S. Inaba, N. Taniguchi, and I. Miyamori
Functional Adrenocorticotropic Hormone Receptor in Cultured Human Vascular Endothelial Cells : Possible Role in Control of Blood Pressure
Hypertension, November 1, 2000; 36(5): 862 - 865.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
N. J. Brown, K.-S. Kim, Y.-Q. Chen, L. S. Blevins, J. H. Nadeau, S. G. Meranze, and D. E. Vaughan
Synergistic Effect of Adrenal Steroids and Angiotensin II on Plasminogen Activator Inhibitor-1 Production
J. Clin. Endocrinol. Metab., January 1, 2000; 85(1): 336 - 344.
[Abstract] [Full Text]


Home page
HypertensionHome page
S. A. Lloyd-MacGilp, S. M. Nelson, M. Florin, M. Lo, J. McKinnell, J. Sassard, and C. J. Kenyon
11{beta}-Hydroxysteroid Dehydrogenase and Corticosteroid Action in Lyon Hypertensive Rats
Hypertension, November 1, 1999; 34(5): 1123 - 1128.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
H. Hatakeyama, S. Inaba, and I. Miyamori
11ß-Hydroxysteroid Dehydrogenase in Cultured Human Vascular Cells : Possible Role in the Development of Hypertension
Hypertension, May 1, 1999; 33(5): 1179 - 1184.
[Abstract] [Full Text] [PDF]


Home page
J. Physiol.Home page
J. P Gardner and L. Zhang
Glucocorticoid modulation of Ca2+ homeostasis in human B lymphoblasts
J. Physiol., January 15, 1999; 514(2): 385 - 396.
[Abstract] [Full Text] [PDF]